National Health Investors NHI WASHINGTON — Purchase price
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration.
The source filing: National Health Investors’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000877860-26-000135
In May 2026, we completed the sale of a property located in Washington in which we had a purchase and sale agreement outstanding as of March 31, 2026. We received $39.0 million in net cash consideration and will recognize a gain of approximately $20.1 million related to the sale. As of March 31, 2026, the net carrying amount of the property was $18.3 million. During the three months ended March 31, 2026 and 2025, we recognized rental income of $0.6 million and $0.7 million, respectively, related to this property.
Item 1. Financial Statements
FAQ
- What is National Health Investors's WASHINGTON — purchase price?
- National Health Investors (NHI) reported WASHINGTON — purchase price of $39M in Q2 2026.
- What does WASHINGTON — purchase price mean?
- This metric represents the total historical acquisition cost of real estate assets located within the Washington geographic market. It serves as a baseline for evaluating the capital intensity and investment scale of the company's regional portfolio. Tracking this figure helps investors assess the company's historical deployment of capital in specific geographic regions.
Ask your AI about National Health Investors's washington — purchase price.
Connect your AI assistant and compare segments, right in your chat.
